Traci Rieckmann1, Laurie Moore1, Calvin Croy1, Gregory A Aarons1, Douglas K Novins1. 1. Dr. Rieckmann is with the School of Public Health, Oregon Health and Science University-Portland State University, Portland. Ms. Moore, Dr. Croy, and Dr. Novins are with the Centers for American Indian and Alaska Native Health, University of Colorado, Aurora. Dr. Novins is also with the Department of Psychiatry, University of Colorado, Aurora. Dr. Aarons is with the Department of Psychiatry and the Child and Adolescent Services Research Center, University of California, San Diego.
Abstract
OBJECTIVE: American Indians and Alaska Natives (AI/ANs) experience higher rates of substance use disorders and less access to high-quality care compared with other racial-ethnic groups. The objective of this study was to better understand the use of medication-assisted treatment (MAT) of substance use disorders for AI/ANs and barriers to broader implementation. METHODS: Representatives of 192 substance abuse treatment programs completed a survey about their use of MAT. On the basis of implementation science frameworks, the authors examined survey items about program structure, workforce, and other services provided in order to develop logistic regression models that explored significant associations between workforce and program characteristics and use of MAT. RESULTS: Of the 192 programs, 28% reported implementing MAT. Multivariate logistic regression models indicated that programs with staff that perceived MAT to be consistent with their program's treatment approach and philosophy and programs reporting that MAT fit with staff expertise and training were more likely to implement MAT. Programs with nurses on staff and those reporting a perceived gap in the use of evidence-based treatments (EBTs) were less likely to implement MAT. CONCLUSIONS: Low rates of MAT implementation suggest racial disparities in access to MAT among AI/ANs, a population with historically high rates of substance use disorders. Study findings also highlight the important role of treatment culture and organizational fit in the implementation of MAT in treatment programs serving AI/AN populations. Results also speak to the importance of adapting existing EBTs in a culturally competent way to best serve the needs of the AI/AN community.
OBJECTIVE: American Indians and Alaska Natives (AI/ANs) experience higher rates of substance use disorders and less access to high-quality care compared with other racial-ethnic groups. The objective of this study was to better understand the use of medication-assisted treatment (MAT) of substance use disorders for AI/ANs and barriers to broader implementation. METHODS: Representatives of 192 substance abuse treatment programs completed a survey about their use of MAT. On the basis of implementation science frameworks, the authors examined survey items about program structure, workforce, and other services provided in order to develop logistic regression models that explored significant associations between workforce and program characteristics and use of MAT. RESULTS: Of the 192 programs, 28% reported implementing MAT. Multivariate logistic regression models indicated that programs with staff that perceived MAT to be consistent with their program's treatment approach and philosophy and programs reporting that MAT fit with staff expertise and training were more likely to implement MAT. Programs with nurses on staff and those reporting a perceived gap in the use of evidence-based treatments (EBTs) were less likely to implement MAT. CONCLUSIONS: Low rates of MAT implementation suggest racial disparities in access to MAT among AI/ANs, a population with historically high rates of substance use disorders. Study findings also highlight the important role of treatment culture and organizational fit in the implementation of MAT in treatment programs serving AI/AN populations. Results also speak to the importance of adapting existing EBTs in a culturally competent way to best serve the needs of the AI/AN community.
Entities:
Keywords:
Alcohol & drug abuse, American Indians/Native Americans, Drug treatment/psychopharmacology, Drug abuse
Authors: Mary E Evans; Marissa Person; Brigg Reilley; Jessica Leston; Richard Haverkate; Jeffrey T McCollum; Andria Apostolou; Michele K Bohm; Michelle Van Handel; Danae Bixler; Andrew J Mitsch; Dana L Haberling; Sarah M Hatcher; Thomas Weiser; Kim Elmore; Eyasu H Teshale; Paul J Weidle; Philip J Peters; Kate Buchacz Journal: Public Health Rep Date: 2020-07-07 Impact factor: 2.792
Authors: Kamilla L Venner; Dennis M Donovan; Aimee N C Campbell; Dennis C Wendt; Traci Rieckmann; Sandra M Radin; Sandra L Momper; Carmen L Rosa Journal: Addict Behav Date: 2018-05-23 Impact factor: 3.913
Authors: Emily G Hichborn; Sarah K Moore; Phoebe R Gauthier; Nico O Agosti; Kathleen D Bell; Jesse S Boggis; Chantal A Lambert-Harris; Elizabeth C Saunders; Avery M Turner; Bethany M McLeman; Lisa A Marsch Journal: JMIR Res Protoc Date: 2022-05-17
Authors: Kathryn Hawk; Ryan McCormack; E Jennifer Edelman; Edouard Coupet; Nicolle Toledo; Phoebe Gauthier; John Rotrosen; Marek Chawarski; Shara Martel; Patricia Owens; Michael V Pantalon; Patrick O'Connor; Lauren K Whiteside; Ethan Cowan; Lynne D Richardson; Michael S Lyons; Richard Rothman; Lisa Marsch; David A Fiellin; Gail D'Onofrio Journal: JAMA Netw Open Date: 2022-01-04
Authors: Dennis C Wendt; Stéphanie Marsan; Daniel Parker; Karen E Lizzy; Jessica Roper; Christopher Mushquash; Kamilla L Venner; Alice Lam; Jennifer Swansburg; Nancy Worth; Nicholas Sorlagas; Tania Quach; Kristapore Manoukian; Payton Bernett; Sandra M Radin Journal: J Subst Abuse Treat Date: 2020-10-09